BRAF V600E MUTATION POSITIVE
Clinical trials for BRAF V600E MUTATION POSITIVE explained in plain language.
Never miss a new study
Get alerted when new BRAF V600E MUTATION POSITIVE trials appear
Sign up with your email to follow new studies for BRAF V600E MUTATION POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug cocktail aims to Re-Sensitize resistant thyroid tumors to radioiodine
Disease control CompletedThis early-phase trial tested two drugs, vemurafenib and copanlisib, in 8 people with advanced thyroid cancer that had stopped responding to radioiodine therapy. The goal was to see if the combination could make tumors sensitive to radioiodine again and shrink them. The study als…
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
Real-World data sheds light on Tough-to-Treat colorectal cancer
Knowledge-focused CompletedThis study looked back at medical records of 274 people with a specific genetic mutation (BRAF V600E) in advanced colorectal cancer. The goal was to see which treatments doctors actually used and how well they worked in everyday practice. No new treatments were tested; instead, r…
Matched conditions: BRAF V600E MUTATION POSITIVE
Sponsor: Pierre Fabre Medicament • Aim: Knowledge-focused
Last updated May 26, 2026 04:27 UTC